Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

363
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
363
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

324
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
324
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

446
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
446

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Instrument flight to the inner ear.

Science robotics·2018
Same author

Localizing seizure-onset zones in presurgical evaluation of drug-resistant epilepsy by electroencephalography/fMRI: effectiveness of alternative thresholding strategies.

AJNR. American journal of neuroradiology·2012
Same author

Corticospinal output during muscular fatigue differs in multiple sclerosis patients compared to healthy controls.

Multiple sclerosis (Houndmills, Basingstoke, England)·2012
Same author

Muscle membrane dysfunction in critical illness myopathy assessed by velocity recovery cycles.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2010
Same author

Corticospinal output and loss of force during motor fatigue.

Experimental brain research·2009
Same author

A novel dominant mutation of the Nav1.4 alpha-subunit domain I leading to sodium channel myotonia.

Neurology·2008

Related Experiment Video

Updated: Apr 6, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

14.7K

[Myositides: What is the current situation?].

K M Rösler1, O Scheidegger

  • 1Neuromuskuläres Zentrum, Neurologische Universitätsklinik, Inselspital, 3010, Bern, Schweiz, kai.roesler@insel.ch.

Zeitschrift Fur Rheumatologie
|July 18, 2015
PubMed
Summary
This summary is machine-generated.

This review covers idiopathic inflammatory myopathies, detailing their classification, diagnosis, and treatment from a neurological perspective. Immunosuppressive therapy shows effectiveness for polymyositis, dermatomyositis, and necrotizing myopathy.

More Related Videos

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.7K

Related Experiment Videos

Last Updated: Apr 6, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

14.7K
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.7K

Area of Science:

  • Neurology
  • Immunology
  • Rheumatology

Context:

  • Idiopathic inflammatory myopathies (IIMs) are a group of rare autoimmune diseases.
  • These conditions affect muscles and can be associated with other systemic diseases or cancer.
  • Understanding IIMs is crucial for accurate diagnosis and effective management.

Purpose:

  • To provide a comprehensive neurological review of IIM classification, diagnosis, and treatment.
  • To outline the key diagnostic criteria and procedures for myositis syndromes.
  • To discuss current treatment strategies and their efficacy.

Summary:

  • IIMs are classified into polymyositis (PM), dermatomyositis (DM), inclusion body myositis (IBM), and necrotizing myopathy (NM), each with distinct clinical and pathophysiological features.
  • Diagnosis relies on clinical presentation, blood tests (creatine phosphokinase, acute phase reactants), electromyography, MRI, and mandatory muscle biopsy.
  • While high-quality treatment trials are limited, immunosuppressive therapy is empirically effective for PM, DM, and NM.

Impact:

  • This review aids neurologists and other specialists in diagnosing and managing patients with inflammatory myopathies.
  • It highlights the importance of a multidisciplinary approach for complex cases, including overlap syndromes.
  • Improved understanding can lead to better patient outcomes and targeted therapeutic strategies.